<DOC>
	<DOCNO>NCT01366157</DOCNO>
	<brief_summary>RATIONALE : Studying sample tissue patient cancer laboratory may help doctor identify learn change occur DNA identify biomarkers related cancer . It may also help doctor predict patient respond treatment . PURPOSE : This research trial study protein biomarker level tissue sample young patient low-risk Hodgkin lymphoma .</brief_summary>
	<brief_title>Protein Biomarker Levels Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : - To investigate variability expression human geminal-center-associated lymphoma ( HGAL ) protein pediatric low-risk Hodgkin lymphoma . - To assess variability HGAL staining risk group compare sample subject enrol low-risk study AHOD0431 subject sample enrol AHOD0031 intermediate-risk classical Hodgkin Lymphoma ( cHL ) . - To assess variability HGAL stain evaluate tissue array create subject intermediate-risk cHL . - To correlate rapid slow early-response intermediate-risk group HGAL protein expression . OUTLINE : Paraffin-embedded tissue sample tissue microarrays analyze protein expression IHC .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosed lowrisk classical Hodgkin lymphoma ( cHL ) Samples available patient enrol lowrisk study COGAHOD0431 intermediaterisk cHL study COGAHOD0031 PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>childhood favorable prognosis Hodgkin lymphoma</keyword>
	<keyword>stage I childhood Hodgkin lymphoma</keyword>
	<keyword>stage II childhood Hodgkin lymphoma</keyword>
	<keyword>stage III childhood Hodgkin lymphoma</keyword>
	<keyword>stage IV childhood Hodgkin lymphoma</keyword>
	<keyword>childhood lymphocyte depletion Hodgkin lymphoma</keyword>
	<keyword>childhood lymphocyte predominant Hodgkin lymphoma</keyword>
	<keyword>childhood mixed cellularity Hodgkin lymphoma</keyword>
	<keyword>childhood nodular lymphocyte predominant Hodgkin lymphoma</keyword>
	<keyword>childhood nodular sclerosis Hodgkin lymphoma</keyword>
</DOC>